Fundamentals of Transplant and Cellular Therapy- Day 2 - CAR-T - Enduring Material - Credit offering period June 16, 2026 - December 31, 2026

Kathleen Farringer, CRNP
* Scientific basis/Immuno-effector cells

 

References:

Michael D. Jain, Melody Smith, Nirali N. Shah; How I treat refractory CRS and ICANS after CAR T-cell therapy. Blood 2023; 141 (20): 2430-2442, doi: https://doi.org/10.1182/blood.2022017414 

https://my.clevelandclinic.org/health/treatments/17726-car-t-cell-therapy

Target Audience

Physicians, nurses, pharmacists, and allied health care professionals who practice in hematological-medical units, skilled nursing facilities, home care, hospice, radiation oncology, surgical oncology, and/or cellular transplant.

Learning Objectives

Discuss mechanism of action

Review approved uses and treatments

Evaluate short- and long-term efficacy 

 

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
Course opens: 
06/16/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0

Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Allegheny General Hospital designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.